<p>Clinical characteristics of <i>EGFR</i> mutation (M) and wildtype (wt) cohorts.</p
<p>COPD, chronic obstructive pulmonary disease; EGFR, epidermal growth factor receptor; ALK, anaplas...
<p>*Light smokers referred to patients who had smoked less than 100 cigarettes in their lifetime.</p...
Clinical characteristics of probands who underwent genetic testing (N = 460).</p
<p>Patient demographics, clinical characteristics and details of EGFR mutation.</p
<p>Clinical and disease characteristics of patients with EGFR gene TKI-sensitive mutations and patie...
<p>Correlation Between <i>EGFR</i> Mutation Subtypes and Clinical Pathological Features.</p
<p>Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-m...
<p>Clinical and disease characteristics of patients enrolled in the analysis of EGFR-TKI therapeutic...
<p>Clinical variables for predicting <i>EGFR</i> activating mutations: Multiple logistic regression ...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
<p>Characteristics of participants with or without 10% of eGFR change per year in each group.</p
<p>Association between <i>EGFR</i> tyrosine kinase mutations and clinical pathological features.</p
<p>Univariate and multivariate analysis of predictors of <i>EGFR</i> mutation.</p
<p>Characteristics of participants with or without 10% of eGFR change per year in each group.</p
*<p>Multivariate analysis included 1,315 patients, and adjusted for gender, age at diagnosis, smokin...
<p>COPD, chronic obstructive pulmonary disease; EGFR, epidermal growth factor receptor; ALK, anaplas...
<p>*Light smokers referred to patients who had smoked less than 100 cigarettes in their lifetime.</p...
Clinical characteristics of probands who underwent genetic testing (N = 460).</p
<p>Patient demographics, clinical characteristics and details of EGFR mutation.</p
<p>Clinical and disease characteristics of patients with EGFR gene TKI-sensitive mutations and patie...
<p>Correlation Between <i>EGFR</i> Mutation Subtypes and Clinical Pathological Features.</p
<p>Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-m...
<p>Clinical and disease characteristics of patients enrolled in the analysis of EGFR-TKI therapeutic...
<p>Clinical variables for predicting <i>EGFR</i> activating mutations: Multiple logistic regression ...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
<p>Characteristics of participants with or without 10% of eGFR change per year in each group.</p
<p>Association between <i>EGFR</i> tyrosine kinase mutations and clinical pathological features.</p
<p>Univariate and multivariate analysis of predictors of <i>EGFR</i> mutation.</p
<p>Characteristics of participants with or without 10% of eGFR change per year in each group.</p
*<p>Multivariate analysis included 1,315 patients, and adjusted for gender, age at diagnosis, smokin...
<p>COPD, chronic obstructive pulmonary disease; EGFR, epidermal growth factor receptor; ALK, anaplas...
<p>*Light smokers referred to patients who had smoked less than 100 cigarettes in their lifetime.</p...
Clinical characteristics of probands who underwent genetic testing (N = 460).</p